Hypoplastic Left Heart Syndrome: Stage I Palliation
With Dr. Meghan M. Chlebowski
Chapter 1 of 4
HLHS anatomy
HLHS Anatomy and Pre-operative Physiology
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Trans-Catheter Interventions: New Horizons in Medical and Surgical Fontan...
CCHMC Pediatric Surgery · 17 min · Published Jul 2017
Video
Update on Surgical Practice and Current State on Fontan Conversion Surgery:...
CCHMC Pediatric Surgery · 25 min · Published Jul 2017
Video
Outcomes of Fontan Patients Undergoing Combined Heart - Liver Transplantation in Pediatric Hospitals Across the U.S.
59 s · Published Dec 2025
Video
How Does the Blood Go Round in Single Ventricles and Fontans? New Horizons in...
CCHMC Pediatric Surgery · 24 min · Published Jul 2017
Video
Malrotation
42 min · Published Nov 2018
More from this expert
Dr. Meghan M. ChlebowskiVideo
ALCAPA (anomalous left coronary artery from the pulmonary artery)
Meghan M. Chlebowski · 5 min · Published Nov 2025
Video
Truncus Aretriosus: a quick overview
Meghan M. Chlebowski · Published Jan 2025
Video
CICU SOS: common life threatening physiology cases in CICU
Meghan M. Chlebowski · 11 min · Published Sep 2024
Video
Double Inlet Left Ventricle (DILV)
Meghan M. Chlebowski · 7 min · Published May 2024
Video
Tetralogy of Fallot with Pulmonary Atresia and MAPCAs 101
Meghan M. Chlebowski · Published Mar 2024
Video
TAPVR: Total Anomalous Pulmonary Venous Return
Meghan M. Chlebowski · 7 min · Published Dec 2023
What the experts said
Hypoplastic left heart syndrome is an underdevelopment of the left-sided structures of the heart.
There are four common anatomical variants that lead to HLHS: mitral atresia and aortic atresia; mitral atresia and aortic stenosis; mitral stenosis and aortic atresia; and mitral stenosis and aortic stenosis.
A subtype associated with worse outcome is when there is mitral atresia and aortic atresia.
A patent PDA is needed for systemic perfusion in unrepaired HLHS with mitral atresia and aortic atresia.
An unrestricted atrial communication is needed to allow shunting of pulmonary venous return from the left atrium to the right atrium in unrepaired HLHS.
In HLHS single ventricle physiology, the right ventricle will pump out a total cardiac output, which will then split into pulmonary blood flow and systemic blood flow based on the balance of PVR and SVR.
Total Q equals Qp plus Qs.
When PVR decreases, blood flow chooses the path of less resistance, resulting in more pulmonary blood flow at the expense of systemic blood flow.
Qp greater than Qs leads to decreased systemic perfusion and pulmonary edema.
To improve systemic output pre-operatively, increase total cardiac output with an attempt to increase Qs while minimizing Qp.
Inotropes such as calcium, epi, and milrinone can increase total cardiac output and Qs.
Oxygen will decrease PVR, therefore makes pulmonary overcirculation worse in HLHS.
With mechanical ventilation, permissive hypercarbia with slight acidosis will increase PVR, therefore modulate for less Qp.
First stage palliation is the Norwood procedure, which involves creating a neo-aorta, a Damus-Kaye-Stansel or an innominate to RPA, a source for pulmonary blood flow (a BTT or Sano shunt), and an atrial septectomy.
The hybrid approach involves PA bands and a PDA stent.
The hybrid approach is considered for those deemed to be a poor surgical candidacy for Norwood palliation, such as prematurity, poor ventricular function, and significant other comorbidities.
BT shunt thrombosis presents with desaturation and low EtCO2.
With normal gas exchange, EtCO2 is 40; with gas exchange impaired by impaired perfusion (shunt thrombosis, pulmonary embolism), EtCO2 is 20.
For BT shunt thrombosis, bedside interventions include activating ECMO, epi spritzer or code epi to increase blood pressure, volume, and heparin bolus 100 units per kg.
For all patients with BT shunt, there will be a bag of heparin lock syringes at the bedside for an amount of 100 units per kg to save time during the emergent situation.